- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
-
Profile
- Financials
ImmuCell (ICCC)
Company Profile
| Quarter (USD) | Sep 25 | Jun 25 | Mar 25 | Dec 24 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Annual (USD) | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Revenue | |||||
| Cost of revenue | |||||
| Operating income | |||||
| Operating margin | |||||
| Net income | |||||
| Net profit margin | |||||
| Cash on hand | |||||
| Change in cash | |||||
| Diluted EPS |
| Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
|---|---|---|---|---|---|---|
| Cash on hand (at last report) | 3.89 mm | 3.89 mm | 3.89 mm | 3.89 mm | 3.89 mm | 3.89 mm |
| Cash burn (monthly) | 704.10 k | (no burn) | 45.10 k | (no burn) | 394.19 k | (no burn) |
| Cash used (since last report) | 3.22 mm | n/a | 206.20 k | n/a | 1.80 mm | n/a |
| Cash remaining | 666.82 k | n/a | 3.68 mm | n/a | 2.08 mm | n/a |
| Runway (months of cash) | 0.9 | n/a | 81.6 | n/a | 5.3 | n/a |
| 13F holders | Current |
|---|---|
| Total holders | 16 |
| Opened positions | 1 |
| Closed positions | 13 |
| Increased positions | 5 |
| Reduced positions | 2 |
| 13F shares | Current |
|---|---|
| Total value | 3.78 bn |
| Total shares | 1.02 mm |
| Total puts | 0.00 |
| Total calls | 0.00 |
| Total put/call ratio | – |
| Largest owners | Shares | Value |
|---|---|---|
| Cresset Asset Management | 264.00 k | $958.33 mm |
| Vanguard | 225.60 k | $818.91 mm |
| Renaissance Technologies | 149.49 k | $542.65 mm |
| Bleichroeder | 101.59 k | $368.79 mm |
| Dimensional Fund Advisors | 72.68 k | $263.83 mm |
| Shufro Rose & Co | 62.41 k | $302.68 mm |
| Geode Capital Management | 56.66 k | $205.73 mm |
| NTRS Northern Trust | 29.39 k | $106.69 mm |
| Prosperity Planning | 16.00 k | $58.08 mm |
| BLK BlackRock | 14.31 k | $51.95 mm |
| Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
|---|---|---|---|---|---|---|---|---|---|---|
| 27 Jan 26 | Boekhorst Paul Francis Olivier te | Stock Options Common Stock | Grant | Acquire A | No | No | 6.265 | 110,000 | 689.15 k | 110,000 |
| 27 Jan 26 | Bobbi Jo Brockmann | Stock Options Common Stock | Grant | Acquire A | No | No | 6.265 | 100,000 | 626.50 k | 100,000 |
| 27 Jan 26 | Timothy C Fiori | Stock Options Common Stock | Grant | Acquire A | No | No | 6.265 | 120,000 | 751.80 k | 120,000 |
| 4 Dec 25 | Boekhorst Paul Francis Olivier te | Common Stock $0.10 par value per share | Buy | Acquire P | No | No | 5.5002 | 2,432 | 13.38 k | 9,738 |
| 3 Dec 25 | Boekhorst Paul Francis Olivier te | Common Stock $0.10 par value per share | Buy | Acquire P | No | No | 5.045 | 3,598 | 18.15 k | 7,306 |
| 3 Dec 25 | Boekhorst Paul Francis Olivier te | Common Stock $0.10 par value per share | Buy | Acquire P | No | No | 5.0406 | 3,521 | 17.75 k | 9,785 |
| 3 Dec 25 | Boekhorst Paul Francis Olivier te | Common Stock $0.10 par value per share | Buy | Acquire P | No | No | 5.003 | 2,556 | 12.79 k | 6,264 |
| 2 Dec 25 | Boekhorst Paul Francis Olivier te | Common Stock $0.10 par value per share | Buy | Acquire P | No | No | 4.8686 | 3,708 | 18.05 k | 3,708 |